Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals

Background: The hepatitis C virus has a high mutation rate, which results in the emergence of resistance-associated substitutions (RASs). Despite direct-acting antivirals (DAAs) efforts to treat chronically infected HCV genotype 3 (GT3) patients, there are concerns about the emergence and persistenc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Saima Mushtaq, Asraf Hussain Hashmi, Amjad Khan, Syed Muhammad Asad Raza Kazmi, Sobia Manzoor
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2022-04-01
Colección:Frontiers in Pharmacology
Materias:
hepatitis C virus
genotype 3
direct-acting antiviral
relapse
resistance-associated substitutions
Acceso en línea:https://www.frontiersin.org/articles/10.3389/fphar.2022.894460/full
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares